Article Versions Notes

Ibrahim MAA, Abdelrahman AHM, Mohamed DEM, Abdeljawaad KAA, Naeem MA, Gabr GA, Shawky AM, Soliman MES, Sidhom PA, Paré PW, et al. Chetomin, a SARS-CoV-2 3C-like Protease (3CL^pro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses. 2023; 15(1):250. https://doi.org/10.3390/v15010250

Ibrahim, Mahmoud A. A., Alaa H. M. Abdelrahman, Dina E. M. Mohamed, Khlood A. A. Abdeljawaad, Mohamed Ahmed Naeem, Gamal A. Gabr, Ahmed M. Shawky, Mahmoud E. S. Soliman, Peter A. Sidhom, Paul W. Paré, and et al. 2023. "Chetomin, a SARS-CoV-2 3C-like Protease (3CL^pro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis" Viruses 15, no. 1: 250. https://doi.org/10.3390/v15010250

Ibrahim, M. A. A., Abdelrahman, A. H. M., Mohamed, D. E. M., Abdeljawaad, K. A. A., Naeem, M. A., Gabr, G. A., Shawky, A. M., Soliman, M. E. S., Sidhom, P. A., Paré, P. W., & Hegazy, M.-E. F. (2023). Chetomin, a SARS-CoV-2 3C-like Protease (3CL^pro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses, 15(1), 250. https://doi.org/10.3390/v15010250